Literature DB >> 18936888

Vancomycin-resistant enterococci (VRE) outbreak at a university hospital in Kitakyushu, Japan: case-control studies.

Tsutomu Hoshuyama1, Hiroyuki Moriguchi, Tetsuro Muratani, Tetsuro Matsumoto.   

Abstract

At a university hospital in Japan, a total of 15 patients (14 adults and 1 newborn baby) with vancomycinresistant enterococci (VRE) infection or colonization (inf/col) were identified via routine clinical examinations and two nonroutine examinations from January to April 2007. Two case-control studies were conducted to identify the factors related to VRE inf/col. In study 1, the patients with VRE inf/col from ward A (n = 8) were compared with all of the patients without VRE isolates in the same ward, i.e., the controls (n = 26). In study 2, all adult patients with VRE inf/col throughout the hospital (n = 14) were compared with controls randomly selected from among all patients without VRE isolates (n = 45). All the subject cases were found to be infected or colonized with Enterococcus faecium, vanB. All but two of the isolated strains were completely identical according to pulsed field gel electrophoresis. Univariate analysis in study 2 showed several factors, including the isolation of methicillin-resistant Staphylococcus aureus (MRSA) (odds ratio [OR], 8.6; 95% confidence interval [CI], 1.3-53.7) and the use of antibiotics other than anti-MRSA drugs (OR, 33.0; 95% CI, 1.8-587.6) to be risk factors for VRE inf/col. Multivariate logistic regression analysis in study 2 demonstrated associations with VRE inf/col in the use of an ultrasound nebulizer (OR, 5.9; 95% CI, 1.5-22.8) and extended bed rest (OR, 3.8; 95% CI, 1.02-24.5). Although severe infection with VRE did not occur, to avoid the spread of VRE in hospital wards, further staff education should be implemented in regard to the usual standard and contact precautions, and the appropriate selection of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936888     DOI: 10.1007/s10156-008-0628-x

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  6 in total

1.  Virulence determinants in vancomycin-resistant Enterococcus faecium vanA isolated from different sources at University Hospital of Londrina, Paraná, Brazil.

Authors:  Flávia Imanishi Ruzon; Suelen Balero de Paula; Renata Lumi Kanoshiki; Jussevania Pereira-Santos; Gilselena Kerbauy; Renata Katsuko Takayama Kobayashi; Lucy Megumi Yamauchi; Márcia Regina Eches Perugini; Sueli Fumie Yamada-Ogatta
Journal:  J Microbiol       Date:  2011-01-09       Impact factor: 3.422

Review 2.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

3.  Successful control of vancomycin-resistant Enterococcus faecium outbreak in a neurosurgical unit at non-endemic region.

Authors:  V C C Cheng; J F W Chan; J W M Tai; Y Y Ho; I W S Li; K K W To; P L Ho; K Y Yuen
Journal:  Emerg Health Threats J       Date:  2010-03-31

4.  A novel termini analysis theory using HTS data alone for the identification of Enterococcus phage EF4-like genome termini.

Authors:  Xianglilan Zhang; Yahui Wang; Shasha Li; Xiaoping An; Guangqian Pei; Yong Huang; Hang Fan; Zhiqiang Mi; Zhiyi Zhang; Wei Wang; Yubao Chen; Yigang Tong
Journal:  BMC Genomics       Date:  2015-05-28       Impact factor: 3.969

5.  Factors associated with acquisition of glycopeptide-resistant enterococci during a single-strain outbreak.

Authors:  S Deboscker; P Schneider; F Séverac; C Ménard; J Gaudart; T Lavigne; N Meyer
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan.

Authors:  Norihiro Saito; Junichi Kitazawa; Hiroko Horiuchi; Takeo Yamamoto; Masahiko Kimura; Fumio Inoue; Mika Matsui; Satoko Minakawa; Masamichi Itoga; Junichiro Tsuchiya; Satowa Suzuki; Junzo Hisatsune; Yoshiaki Gu; Motoyuki Sugai; Hiroyuki Kayaba
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-23       Impact factor: 6.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.